Cyclophosphamate

DRUG2 trials

Sponsors

National Institute of Mental Health (NIMH), M.D. Anderson Cancer Center

Conditions

Alzheimer's DiseaseClear Cell CarcinomaGrowth FactorPhase 1

Phase 1

Effects of an Anti-Inflammatory Drug in Alzheimer's Disease

CompletedNCT00013650

National Institute of Mental Health (NIMH)Alzheimer's Disease

Start: 2001-03-22End: 2008-04-21Target: 60Updated: 2017-07-02

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

RecruitingNCT07072234

M.D. Anderson Cancer CenterClear Cell Carcinoma, Growth Factor, Phase 1

Start: 2025-09-25End: 2030-02-01Target: 30Updated: 2025-10-07